Table 2.
Age group | Placebo | Drug (Ars alb-30) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BP | AP 1M | BD | AD 1M | |||||||||||||||||||||
Male | Female | Male | Female | Male | Female | Male | Female | |||||||||||||||||
+ve | B | −ve | +ve | B | −ve | +ve | B | −ve | +ve | B | −ve | +ve | B | −ve | +ve | B | −ve | +ve | B | −ve | +ve | B | −ve | |
<20 years | 1 | 0 | 12 | 0 | 0 | 1 | 1 | 0 | 12 | 0 | 0 | 1 | 0 | 1 | 3 | 2 | 0 | 4 | 0 | 0 | 4 | 1 NA1 | 0 | 4 |
20–40 years | 2 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 2 | 4 | 3 | 3 | 0 | 0 | 3 | 0 | 0 | 10 |
>40 years | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
Total populations studied, 43: Placebo fed, 17 (Male 16, Female 1); Drug (Ars alb-30) fed, 26 (Male 9, Female 17); NA = blood not available (dropped out), BP = before administration of placebo; AP = after administration of placebo; BD = before administration of the drug; AD = after administration of the drug, 1M = one month.